Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1001 - 1100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1001 | 26821025 |
US |
69 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1002 | 26821051 |
US |
74 | 2 |
Rash, Dermatitis atopic, Neurodermatitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1003 | 26821333 |
US |
7 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1004 | 26821339 |
US |
2 | |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, ROSUVASTATIN, DOXEPIN HYDROCHLORIDE, DOXEPN HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, FLURANDRENOLIDE, GLIMEPIRIDE, IRON, EMPAGLIFLOZIN, ORAL SEMAGLUTIDE, PANTOPRAZOLE SODIUM, VITAMIN C, ERGOCALCIFEROL, EZETIMIBE, |
||||
| 1005 | 26821358 |
US |
1 | |
Seasonal allergy, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1006 | 26821373 |
US |
19 | 2 |
Musculoskeletal stiffness, Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 1007 | 26821390 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1008 | 26821512 |
US |
2 | |
Rash erythematous, Dermatitis atopic, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DUPILUMAB, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELASTINE HYDROCHLORIDE, AZELASTINE, CALCIUM, CARVEDILOL, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, HYOSCYAMINE SULFATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, TIRZEPATIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, EVOLOCUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 1009 | 26821530 |
US |
78 | |
Neuropathy peripheral, Rash, Dry skin, Skin hyperpigmentation, Skin ulcer, Headache, Dermatitis atopic, |
||||
| 1010 | 26821713 |
US |
13 | 2 |
Dermatitis atopic, Drug ineffective, Skin burning sensation, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 1011 | 26822096 |
US |
30 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1012 | 26822102 |
US |
12 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1013 | 26822103 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1014 | 26822104 |
US |
1 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1015 | 26822109 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1016 | 26822163 |
US |
9 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1017 | 26822598 |
US |
60 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1018 | 26822615 |
US |
2 | 1 |
Conjunctivitis, Dermatitis atopic, Rash, |
||||
DUPILUMAB, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, MUPIROCIN, MUPIROCIN CALCIUM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1019 | 26822623 |
US |
48 | 2 |
Dermatitis atopic, Dry eye, |
||||
DUPILUMAB, |
||||
| 1020 | 26822635 |
US |
27 | 1 |
Sleep disorder, Eczema, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1021 | 26822685 |
US |
71 | 1 |
Diabetic foot, Fatigue, Dermatitis atopic, Therapeutic product effect decreased, Rash, Product dose omission in error, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 1022 | 26822883 |
US |
66 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1023 | 26822895 |
US |
41 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1024 | 26823540 |
US |
82 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1025 | 26823715 |
US |
1 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CEPHALEXIN, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, PREDNISONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1026 | 26823718 |
US |
8 | 2 |
Dermatitis atopic, Skin fissures, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1027 | 26823968 |
US |
23 | 2 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 1028 | 26823979 |
US |
1 | |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1029 | 26824136 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1030 | 26824143 |
US |
55 | 1 |
Dermatitis atopic, Pruritus, Therapeutic response decreased, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1031 | 26824237 |
US |
||
Dermatitis atopic, Product physical issue, |
||||
RUXOLITINIB, DUPILUMAB, |
||||
| 1032 | 26824310 |
US |
2 | |
Dermatitis atopic, Pruritus, Dry skin, |
||||
DUPILUMAB, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, BENZOYL PEROXIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, SUMATRIPTAN SUCCINATE, TRETINOIN, NORGESTIMATE AND ETHINYL ESTRADIOL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, |
||||
| 1033 | 26824914 |
US |
4 | 2 |
Dermatitis atopic, Skin erosion, Pruritus, Dry skin, Ocular hyperaemia, Eyelid exfoliation, Rash, |
||||
DUPILUMAB, MOMETASONE FUROATE, MOMETASONE, DESOXIMETASONE, ROFLUMILAST, |
||||
| 1034 | 26817694 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1035 | 26817702 |
US |
27 | 1 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1036 | 26817707 |
US |
43 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1037 | 26817788 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, CALCIUM, FAMOTIDINE, HYDROXYZINE, |
||||
| 1038 | 26817823 |
US |
1 | |
Dermatitis atopic, Infection, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1039 | 26817862 |
US |
12 | 1 |
Dermatitis contact, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1040 | 26817932 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1041 | 26817935 |
US |
25 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1042 | 26817944 |
US |
59 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1043 | 26818035 |
US |
59 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1044 | 26818087 |
US |
2 | |
Rash macular, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1045 | 26818125 |
US |
38 | 2 |
Dermatitis atopic, Rash, Therapeutic response shortened, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 1046 | 26818131 |
US |
11 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1047 | 26818148 |
US |
54 | 2 |
Dermatitis atopic, Rash erythematous, Pruritus, |
||||
DUPILUMAB, |
||||
| 1048 | 26818149 |
US |
76 | 1 |
Eye pain, Glare, Pruritus, Therapeutic response decreased, Dry eye, Drug hypersensitivity, Dermatitis atopic, Skin plaque, Rash, |
||||
DUPILUMAB, DUPILUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, ALLOPURINOL, ALPRAZOLAM, ERGOCALCIFEROL, MAGNESIUM, POTASSIUM CITRATE, |
||||
| 1049 | 26818173 |
GB |
22 | 2 |
Dermatitis atopic, Depressed mood, |
||||
UPADACITINIB, |
||||
| 1050 | 26818183 |
US |
3 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1051 | 26818194 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, LOVASTATIN, |
||||
| 1052 | 26818216 |
US |
2 | |
Dermatitis atopic, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1053 | 26818327 |
US |
2 | |
Dermatitis atopic, Ankle operation, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1054 | 26818336 |
US |
38 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1055 | 26818384 |
US |
45 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1056 | 26818428 |
US |
19 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1057 | 26818433 |
US |
85 | 1 |
Dermatitis atopic, Symptom recurrence, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1058 | 26818447 |
US |
17 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1059 | 26818517 |
US |
66 | 2 |
Tooth infection, Condition aggravated, Productive cough, Pyrexia, Tongue erythema, Swollen tongue, Infective glossitis, Glossodynia, Injection site pain, Dermatitis atopic, Mouth swelling, Gingival pain, Nervous system disorder, Tongue injury, |
||||
DUPILUMAB, |
||||
| 1060 | 26818519 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1061 | 26818536 |
US |
2 | |
Sensitivity to weather change, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1062 | 26818567 |
US |
52 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1063 | 26818581 |
US |
13 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1064 | 26818605 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1065 | 26818720 |
US |
77 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1066 | 26818729 |
US |
60 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1067 | 26818736 |
US |
9 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1068 | 26818765 |
US |
8 | 1 |
Dermatitis atopic, Dry eye, Incorrect dose administered, |
||||
DUPILUMAB, ALBUTEROL SULFATE, EPINEPHRINE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1069 | 26818769 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1070 | 26818807 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1071 | 26818836 |
US |
44 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 1072 | 26818856 |
US |
60 | 1 |
Dermatitis atopic, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 1073 | 26818892 |
US |
77 | 1 |
Dermatitis atopic, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 1074 | 26818953 |
US |
71 | 2 |
Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, |
||||
| 1075 | 26819004 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1076 | 26819019 |
US |
2 | |
Dermatitis atopic, Rash pruritic, |
||||
DUPILUMAB, CHLORTHALIDONE, |
||||
| 1077 | 26819165 |
US |
1 | |
Dermatitis atopic, Back pain, |
||||
DUPILUMAB, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, IRBESARTAN, IRBESARTAN, FAMOTIDINE, TAMSULOSIN HYDROCHLORIDE, ORAL SEMAGLUTIDE, |
||||
| 1078 | 26819241 |
US |
13 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1079 | 26819242 |
US |
13 | 1 |
Dermatitis atopic, Rash vesicular, |
||||
DUPILUMAB, |
||||
| 1080 | 26813067 |
US |
14 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1081 | 26813235 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1082 | 26813468 |
US |
42 | 2 |
Autoimmune disorder, Arthralgia, Stress, Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, CETIRIZINE HCL, CETIRIZINE, FLUTICASONE PROPIONATE, HYDROXYCHLOROQUINE SULFATE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 1083 | 26813471 |
US |
13 | 2 |
Dermatitis atopic, Pruritus, Scratch, Pain of skin, |
||||
DUPILUMAB, |
||||
| 1084 | 26813477 |
US |
77 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1085 | 26813482 |
US |
73 | 1 |
Dermatitis atopic, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 1086 | 26813668 |
US |
48 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1087 | 26813757 |
US |
71 | 2 |
Dermatitis atopic, Urticaria, Pruritus, Inflammation, |
||||
DUPILUMAB, |
||||
| 1088 | 26813765 |
US |
25 | 2 |
Dermatitis atopic, Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1089 | 26814020 |
US |
2 | |
Dermatitis atopic, Malaise, |
||||
DUPILUMAB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, APREMILAST, PREDNISONE, PROGESTERONE, |
||||
| 1090 | 26814023 |
US |
43 | 2 |
Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1091 | 26814034 |
US |
47 | 2 |
Bronchitis, Dermatitis atopic, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE, MAGNESIUM, MONTELUKAST SODIUM, |
||||
| 1092 | 26814310 |
US |
64 | 2 |
Vision blurred, Dry eye, Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1093 | 26814319 |
US |
2 | |
Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 1094 | 26814602 |
US |
77 | 2 |
Urticaria, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1095 | 26814612 |
US |
1 | |
Cutaneous T-cell lymphoma, Condition aggravated, Deformity, Injury, Anxiety, Pain, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1096 | 26815115 |
US |
49 | 1 |
Major depression, Transient ischaemic attack, Cerebral infarction, Type 2 diabetes mellitus, Colon cancer, Psoriatic arthropathy, Peripheral vascular disorder, Lung disorder, Anaemia, Dermatitis, Arthralgia, Essential hypertension, Abnormal faeces, Rash, Pruritus, Drug hypersensitivity, Dermatitis atopic, Chronic obstructive pulmonary disease, Acute sinusitis, Generalised anxiety disorder, Hyperkaliuria, |
||||
EVOLOCUMAB, |
||||
| 1097 | 26815157 |
US |
1 | 2 |
Dermatitis atopic, Skin irritation, Dry skin, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 1098 | 26815177 |
US |
2 | |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 1099 | 26815200 |
US |
62 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1100 | 26815497 |
US |
63 | 2 |
Gluten sensitivity, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30